(Q61831118)

English

Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion—A Consensus Document fn1fn1This study was supported in part by Abbott Laboratories, Abbott Park, Illinois; Behringweike AG, Marburg, Germany; Boehringer Ingelheim UK, Brackn

article

In more languages

Statements

scholarly article

0 references

Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion—A Consensus Document fn1fn1This study was supported in part by Abbott Laboratories, Abbott Park, Illinois; Behringweike AG, Marburg, Germany; Boehringer Ingelheim UK, Brackn (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

language of work or name

0 references

publication date

January 1998

0 references

American Journal of Cardiology

0 references

81

0 references

2

0 references

207-218

0 references

Thrombolysis in the management of limb arterial occlusion. Towards a consensus interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Computerized angiographic analysis of the outcome of peripheral thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Comparative effectiveness of intravenous and intra-arterial fibrinolysin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Selective Clot Lysis with Low-Dose Streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Low dose streptokinase in the treatment of arterial occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Acceleration of thrombolysis with a high-dose transthrombus bolus technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Local low-dose thrombolytic therapy of peripheral arterial occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraarterial fibrinolytic therapy for popliteal and tibial artery obstruction: comparison of streptokinase and urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Pulse-spray thrombolysis: the "careful analysis"

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Is thrombolysis of occluded popliteal and tibial bypass grafts worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Percutaneous aspiration thromboembolectomy to manage the embolic complications of angioplasty and as an adjunct to thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Percutaneous aspiration thromboembolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Catheter for percutaneous thrombectomy: first clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Rotational atherectomy for treatment of occluded prosthetic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Fibrinolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high dose urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolytic Agents in Development

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Recombinant staphylokinase variants with altered immunoreactivity. IV: Identification of variants with reduced antibody induction but intact potency

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Transcutaneous ultrasound augments lysis of arterial thrombi in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Low-dose intravascular fibrinolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator--report of a pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intra-arterial thrombolysis using recombinant tissue plasminogen activator (r-TPA): the optimal agent, at the optimal dose?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Peripheral thrombolysis: state of the art

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Acute arterial thrombosis of the lower extremity. Its natural history contrasted with arterial embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Surgical treatment versus thrombolysis in acute arterial occlusion: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Practice guidelines: lower extremity revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Advances in thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intra-operative arteriography in arterial embolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative Angiography in the Immediate Assessment of Arterial Reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative fibrinolytic therapy: experimental evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Complications of transluminal angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Percutaneous atherectomy as an alternative treatment for postangioplasty obstructive intimal flaps

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Prophylactic Antiplatelet Therapy in Peripheral Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Aspirin improves the outcome of intra-arterial thrombolysis with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Production and characterisation of human recombinant single chain urokinase-type plasminogen activator from mouse cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Designing thrombolytic agents: focus on safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Fibrinolysis in chronic arteriosclerotic occlusions: intrathrombotic injections of streptokinase. Work in progress.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraarterial fibrinolysis: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Limitations to the widespread usage of low-dose intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Low-dose intra-arterial thrombolysis in the treatment of occluded vascular grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Choice of agent for peripheral thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Long-term results of a single protocol for thrombolysis in acute lower-limb ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intra-arterial thrombolytic therapy in the management of acute and chronic limb ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Complications of intraarterial urokinase-lys-plasminogen infusion therapy in arterial ischemia of lower limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

In situ thrombolysis for late occlusion of suprafemoral prosthetic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Continuous postoperative intra-arterial urokinase infusion in the treatment of no reflow following revascularization of the acutely ischemic limb

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Experience with pulse-spray technique in peripheral thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Occluded peripheral arteries and bypass grafts: lytic stagnation as an end point for pulse-spray pharmacomechanical thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative streptokinase: a useful adjunct to balloon-catheter embolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative use of thrombolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Thrombolysis in the treatment of lower extremity occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative fibrinolytic therapy for salvage of limbs with acute arterial ischemia: an adjunct to thromboembolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Intraoperative catheter thrombolysis as an adjunct to surgical revascularisation for infrainguinal limb-threatening ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900894-1

7 January 2021

Identifiers

10.1016/S0002-9149(97)00894-1

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61831118&oldid=1832108120"